{"gene":"DLX5","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":1999,"finding":"Dlx5 null mice exhibit craniofacial abnormalities, vestibular malformations, and defective osteogenesis, establishing that Dlx5 is required for patterning of branchial arch derivatives, morphogenesis of the vestibular organ, and osteoblast differentiation in vivo.","method":"Targeted gene knockout (null allele replacing exons I and II with lacZ); phenotypic analysis of homozygous mutants","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined phenotypic readouts, replicated in two independent knockout studies (PMIDs 10433909 and 10433912)","pmids":["10433909","10433912"],"is_preprint":false},{"year":1999,"finding":"Dlx5 is a direct transcriptional target of BMP signaling (BMP-2 and BMP-4) in osteoblastic cells; overexpression of Dlx5 in MC3T3-E1 cells increases alkaline phosphatase activity, osteocalcin production, and mineralization, demonstrating a functional role in osteoblast differentiation downstream of BMP.","method":"BMP-inducible gene isolation; stable transfection overexpression assay; osteogenic marker measurement","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function in osteoblasts with multiple orthogonal osteogenic readouts, replicated across multiple subsequent studies","pmids":["10075846"],"is_preprint":false},{"year":1998,"finding":"DLX5 and MSX2 form dimers via their homeodomain regions; DLX5 (residues 127–143) de-represses Msx2-mediated transcriptional repression of the osteocalcin promoter by antagonizing Msx2 binding and restoring OCFREB binding activity, without requiring its own intrinsic DNA-binding activity.","method":"Far-Western blot (protein-protein interaction); transient cotransfection/luciferase reporter assay; structure-function deletion analysis; EMSA","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (far-Western, EMSA, reporter assay, mutagenesis) in single rigorous study","pmids":["9819228"],"is_preprint":false},{"year":2003,"finding":"DLX5 is an indispensable mediator of BMP-2-induced Runx2 expression in C2C12 cells; DLX5 is immediately induced by BMP-2 (cycloheximide-resistant), whereas Runx2 induction requires de novo protein synthesis. Antisense blocking of Dlx5 abolishes BMP-2-induced Runx2 expression. TGF-β1 opposes BMP-2-induced osteogenesis by suppressing Dlx5 expression through de novo AP-1 induction.","method":"Cycloheximide treatment; antisense knockdown; overexpression in C2C12 cells; osteogenic marker assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — epistasis established by antisense blocking and overexpression with multiple markers, replicated across multiple subsequent studies","pmids":["12815054"],"is_preprint":false},{"year":2003,"finding":"BMP-2-induced Osterix expression requires Dlx5 but not Runx2: Osx is still induced by BMP-2 in Runx2-null cells, but antisense blocking of Dlx5 completely abrogates BMP-2-induced Osx expression.","method":"Antisense Dlx5 knockdown; BMP-2 treatment in Runx2-null cells; gene expression analysis","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — epistasis established using null cells and antisense blocking, replicated in subsequent study (PMID 18056716)","pmids":["12963046"],"is_preprint":false},{"year":2001,"finding":"DLX5 interferes with MSX2-Runx2 protein-protein interaction and relieves MSX2-mediated repression of Runx2 transcriptional activity; a missense mutation of MSX2 (P148H) associated with craniosynostosis retains ability to bind and repress Runx2, but is insensitive to DLX5 counter-regulation.","method":"Co-immunoprecipitation; transcriptional reporter assays; domain mapping","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 2 — protein-protein interaction and functional data with disease-relevant mutant as control","pmids":["11683913"],"is_preprint":false},{"year":2004,"finding":"DLX5 directly binds a cis-acting element in the alkaline phosphatase promoter (identified by EMSA and site-directed mutagenesis) and transactivates ALP expression; MSX2 competes with DLX5 for this same element to suppress ALP expression; DLX5-stimulated ALP activity is independent of Runx2.","method":"EMSA; site-directed mutagenesis; promoter-reporter assay; Runx2-null cell experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct DNA-binding confirmed by EMSA and mutagenesis, functional independence from Runx2 shown in null cells","pmids":["15383550"],"is_preprint":false},{"year":2005,"finding":"DLX5 specifically transactivates the Runx2 type II (P1 distal) promoter by binding to three homeodomain-response elements between −756 and −342 bp; this activity is confirmed by gel mobility shift assay and site-directed mutagenesis and is antagonized by MSX2 at the same region.","method":"Promoter deletion analysis; gel mobility shift assay (EMSA); site-directed mutagenesis; reporter assay; overexpression in C2C12 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct DNA binding confirmed by EMSA and mutagenesis of specific response elements","pmids":["16115867"],"is_preprint":false},{"year":2002,"finding":"Dlxin-1 (MAGE/Necdin family protein) directly binds DLX5 (and DLX7 and MSX2) and activates DLX5-dependent transcription; interaction confirmed by yeast two-hybrid, GST pulldown, and co-immunoprecipitation.","method":"Yeast two-hybrid screening; GST pulldown; co-immunoprecipitation; reporter gene assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple methods (Y2H, pulldown, Co-IP, reporter) confirm binding and functional activation","pmids":["11084035"],"is_preprint":false},{"year":2002,"finding":"The RING finger E3 ubiquitin ligase Praja1 binds the C-terminal necdin homology domain of Dlxin-1 and promotes its ubiquitin-dependent proteasomal degradation, thereby down-regulating DLX5-dependent transcriptional activity.","method":"Yeast two-hybrid; GST pulldown; co-immunoprecipitation; proteasome inhibitor rescue; in vivo ubiquitination assay; RING mutant; GAL4 reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted ubiquitination, mutagenesis of RING domain, proteasome inhibitor rescue, multiple orthogonal methods","pmids":["11959851"],"is_preprint":false},{"year":2007,"finding":"DLX5 binds to homeodomain-response elements in the Osterix promoter (confirmed by EMSA and ChIP), and is phosphorylated by p38 MAPK at Ser-34 and Ser-217 in vitro and in vivo; this phosphorylation increases DLX5 transactivation potential and is required for full BMP-2-induced Osterix induction.","method":"EMSA; ChIP; in vitro kinase assay; site-directed mutagenesis (Ser-34/217); overexpression and knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation + mutagenesis + in vivo ChIP confirm direct mechanism","pmids":["18056716"],"is_preprint":false},{"year":2004,"finding":"MeCP2 recruits histone deacetylase 1 (HDAC1) to the Dlx5-Dlx6 locus in mouse brain, promotes repressive H3K9 methylation at this ~1-kb region, and mediates formation of an 11-kb silent chromatin loop at the locus; loss of MeCP2 (in Mecp2-null mice) abolishes this loop and de-represses Dlx5-Dlx6 expression approximately two-fold.","method":"ChIP; chromatin loop assay (ChIP-loop); Mecp2-null mouse brains; allele-specific expression analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — ChIP and loop assay in wild-type vs. null mice; novel mechanism validated by multiple chromatin methods","pmids":["15608638"],"is_preprint":false},{"year":2002,"finding":"Combined inactivation of Dlx5 and Dlx6 in mice causes homeotic-like transformation of the lower jaw into an upper jaw (gain of symmetry), demonstrating that Dlx5/Dlx6 together specify mandibular/lower jaw identity in the first pharyngeal arch.","method":"Double knockout mice; skeletal phenotype analysis","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with strong morphological phenotype establishing homeotic function","pmids":["12434331"],"is_preprint":false},{"year":2002,"finding":"Combined deletion of Dlx5 and Dlx6 in mice causes severe craniofacial, axial, and appendicular skeletal defects phenocopying split-hand/foot malformation (SHFM); transgenic overexpression of Dlx5 specifically in the apical ectodermal ridge fully rescues limb outgrowth in Dlx5/6 null mice, demonstrating that AER-expressed Dlx5 is sufficient for this function.","method":"Double knockout mice; tissue-specific transgenic rescue experiment","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue by tissue-specific transgene establishes tissue-autonomous requirement","pmids":["12000792"],"is_preprint":false},{"year":2002,"finding":"The Dlx5 homeobox gene is essential for vestibular morphogenesis through regulation of BMP4 expression: Dlx5 null mice lack semicircular canals and have severely reduced BMP4 expression in the otic vesicle, while Nkx5.1, Pax2, and Lfng expression is unchanged.","method":"Dlx5 null mouse analysis; in situ hybridization for downstream genes; comparative marker analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — KO with specific downstream target (BMP4) identified by in situ hybridization","pmids":["12142028"],"is_preprint":false},{"year":2004,"finding":"During osteoblast differentiation, a temporal molecular switch occurs at the osteocalcin gene promoter: Msx2 occupies it in proliferating osteoblasts (repressing transcription), while Dlx3, Dlx5, and Runx2 are recruited post-proliferatively to activate transcription; Dlx5 occupancy increases over Dlx3 at the mineralization stage. Dlx3 and Runx2 directly interact (mapped to Runx2 residues 376–432).","method":"Chromatin immunoprecipitation (ChIP); co-immunoprecipitation; reporter assay; RNA interference knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 — ChIP-based temporal chromatin occupancy combined with protein-protein interaction and functional assays","pmids":["15456894"],"is_preprint":false},{"year":2009,"finding":"DLX5 directly binds the IRS-2 promoter (confirmed by ChIP and luciferase assay) and augments its transcription; DLX5-driven cell proliferation in ovarian cancer cells operates through the IRS-2-AKT signaling axis, as knockdown of IRS-2 and MET suppresses AKT phosphorylation downstream of DLX5.","method":"ChIP; luciferase reporter assay; shRNA stable knockdown; constitutively active AKT rescue; xenograft tumor growth assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1 — direct promoter binding confirmed by ChIP and mutagenesis, rescued by AKT overexpression","pmids":["21045156"],"is_preprint":false},{"year":2009,"finding":"DLX5 directly binds two sites in the MYC promoter (confirmed by EMSA and ChIP) and specifically activates MYC transcription in a dose-dependent manner; DLX5-mediated cell proliferation is rescued by MYC overexpression following DLX5 knockdown, placing MYC downstream of DLX5.","method":"Luciferase reporter assay; EMSA; ChIP; siRNA knockdown; MYC overexpression rescue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — direct DNA binding confirmed by EMSA and ChIP, functional rescue confirms linear pathway","pmids":["19497851"],"is_preprint":false},{"year":2009,"finding":"DLX5 is a cell-autonomous regulator of chondrocyte hypertrophy during endochondral ossification: Col2a1-Dlx5 transgenic mice with chondrocyte-restricted Dlx5 expression show accelerated chondrocyte hypertrophy and mineralization, and this transgene specifically rescues the chondrocyte differentiation defects of Dlx5/6 null mice. Dlx5 and Dlx6 are functionally equivalent in this context.","method":"Chondrocyte-specific transgenic expression (Col2a1 promoter); rescue of Dlx5/6 null phenotype","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — cell-type specific transgene with null rescue establishes cell-autonomous function","pmids":["19956613"],"is_preprint":false},{"year":2008,"finding":"Dlx5 null osteoblasts show reduced expression of Runx2, Osterix, Osteocalcin, and Bone Sialoprotein; Dlx5(-/-) femurs have increased osteoclast numbers and Dlx5(-/-) osteoblasts show a higher RANKL/OPG ratio, inducing more TRAP-positive multinucleated osteoclast-like cells in co-culture. This establishes Dlx5 as a regulator of osteoblast-osteoclast coupling.","method":"Dlx5 null mouse embryo analysis; osteoblast culture; RANKL/OPG expression analysis; spleen cell co-culture osteoclastogenesis assay","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — KO with defined molecular mechanism (RANKL/OPG ratio) and functional co-culture readout","pmids":["18669617"],"is_preprint":false},{"year":2009,"finding":"CaMKII phosphorylates DLX5, increases its protein stability, and increases its osteoblastogenic transactivation activity; the CaMKII inhibitor KN-93 decreases osteogenic and transactivation activities of Dlx5.","method":"In vitro kinase assay; protein stability assay; transcriptional reporter assay; pharmacological inhibition","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro kinase assay with functional consequences, single lab","pmids":["19393622"],"is_preprint":false},{"year":2010,"finding":"AMPK activation (via AICAR or metformin) stimulates osteoblast differentiation through Smad1/5/8 phosphorylation → Dlx5 expression → Runx2 expression; siRNA knockdown of Dlx5 suppresses metformin-induced Runx2 expression, placing Dlx5 downstream of AMPK/Smad signaling and upstream of Runx2.","method":"AMPK activator/inhibitor pharmacology; dominant-negative AMPK; siRNA knockdown; BRE-Luc and Runx2-Luc reporter assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placement via siRNA epistasis, single lab","pmids":["21187071"],"is_preprint":false},{"year":2014,"finding":"Dlx5 and Mef2 directly bind to a conserved 343-bp osteoblast-specific enhancer ~30 kb upstream of the Runx2 distal promoter (confirmed by ChIP); their binding sites are required for osteoblast-specific Runx2 expression in mice; other factors (Tcf7, Ctnnb1, Sp7, Smad1, Sox6) bind through protein-protein interactions.","method":"BAC reporter mouse; serial deletion; ChIP in primary osteoblasts; histone modification analysis; enhancer binding site mutagenesis in vivo","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1 — direct ChIP binding and in vivo mutagenesis of binding sites in transgenic mice","pmids":["24692107"],"is_preprint":false},{"year":2014,"finding":"DLX5 is a direct transcriptional target of the FGF8 locus and participates in a regulatory loop with p63 and Pin1: DLX5 activates FGF8 expression, while FGF8 counteracts Pin1-ΔNp63α interaction; Pin1 negatively regulates ΔNp63α protein stability via proteasomal degradation; p63 mutants associated with SHFM/EEC are resistant to Pin1 action.","method":"In vivo ChIP; luciferase reporter; co-immunoprecipitation; proteasome assay; mouse embryo analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — regulatory loop established with ChIP and functional assays, single lab","pmids":["24569166"],"is_preprint":false},{"year":2011,"finding":"Dlx5 identifies direct target genes in the inner ear by gene expression profiling of wild-type vs. Dlx5-null otic vesicles; ChIP confirms DLX5 directly binds promoters of Atbf1, Bmper, Large, Lrrtm1, Msx1, Ebf1, and Lhx1, with Bmper and Lrrtm1 being up-regulated upon Dlx5 overexpression, supporting BMP signaling as downstream of Dlx5 in the inner ear.","method":"Gene expression profiling (microarray); ChIP with Dlx5 antibody in overexpressing cell line; motif analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP confirms direct binding to multiple promoters, supported by expression data","pmids":["21227998"],"is_preprint":false},{"year":2010,"finding":"Hand2 represses Dlx5 and Dlx6 expression in the distal mandibular arch ectomesenchyme as part of a negative-feedback loop (Dlx5/6 first induce Hand2, which then represses Dlx5/6); failure to repress Dlx5/6 leads to upregulation of Runx2 and aberrant bone formation, and aglossia due to absent lateral lingual swelling.","method":"Conditional knockout mouse; genetic epistasis (Hand2 and Dlx5/6 compound mutants); in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in compound mutants with mechanistic pathway placement","pmids":["21558373"],"is_preprint":false},{"year":2009,"finding":"Dlx5 loss leads to reduced Fgf7 expression and expanded Shh signaling in the palatal mesenchyme; this expanded Shh signaling rescues palatal expansion and fusion in Msx1-null mice. Exogenous Fgf7 inhibits Shh signaling and reverses this rescue in Msx1/Dlx5 double knockout palates.","method":"Dlx5 null and Msx1/Dlx5 double-KO mouse analysis; exogenous Fgf7 treatment; in situ hybridization; genetic epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (double KO rescue) with exogenous factor reversal confirms pathway","pmids":["19934017"],"is_preprint":false},{"year":2008,"finding":"TGF-β signaling in cranial neural crest cells suppresses Dlx5 expression and maintains chondrogenic potential; conditional inactivation of Tgfbr2 in CNC cells leads to elevated Dlx5 expression and accelerated osteoprogenitor differentiation at the expense of chondrogenesis; deletion of Dlx5 in Tgfbr2 CNC conditional knockout mice rescues cartilage formation in the angular processes.","method":"Conditional knockout (Tgfbr2flox; Wnt1-Cre); Dlx5/Tgfbr2 compound conditional KO rescue; in situ hybridization; exogenous TGF-β treatment","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — compound conditional KO rescue definitively places Dlx5 downstream of TGF-β signaling in osteo-chondrogenic lineage determination","pmids":["18684439"],"is_preprint":false},{"year":2017,"finding":"Dlx5 in cranial neural crest cells controls FGF10 signaling to regulate interaction between CNC-derived cells and pharyngeal mesoderm-derived myoblasts during soft palate development; FGF10 pathway is downregulated in Dlx5 null mice and exogenous FGF10 rescues CNC cell proliferation and myogenic differentiation.","method":"Dlx5 null mouse analysis; exogenous FGF10 rescue; CNC-myoblast interaction analysis; proliferation and apoptosis assays","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — KO phenotype with ligand rescue identifies downstream pathway, single lab","pmids":["28982687"],"is_preprint":false},{"year":2016,"finding":"DLX5 and DLX6 reciprocally inhibit BMP/HAND2-mediated activation of the Hand1 enhancer in the mandibular arch distal cap; DLX5/DLX6 homeodomain proteins thus exclude formation of the Hand1-positive distal cap domain from Dlx5/6-expressing proximal domains.","method":"Enhancer reporter assay; co-transfection with DLX5/6; genetic analysis in Dlx5/6 null embryos","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay with DLX5/6 and null embryo validation, single lab","pmids":["27335460"],"is_preprint":false},{"year":2021,"finding":"DLX5 cooperates with the master transcription factor TP63 in regulating approximately 2000 enhancers and promoters in squamous cell carcinoma; DLX5 promoter gains active histone marks via SOX2-mediated activation in ESCC (vs. bivalent/silenced state in normal tissue); DLX5 silencing inhibits SCC viability in vitro and in vivo.","method":"ATAC-seq/ChIP-seq (bivalent chromatin analysis); computational ELMER analysis; shRNA knockdown; xenograft assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple chromatin methods establishing co-regulatory mechanism, single lab","pmids":["34370013"],"is_preprint":false},{"year":2015,"finding":"Dlx5 regulates olfactory receptor neuron differentiation via miR-9 and miR-200 class microRNAs; Dlx5 null olfactory epithelium has reduced miR-9, miR-376a, and miR-200 class expression; miR-9 and miR-200 negatively regulate Foxg1 mRNA, and elevated Foxg1 (in the absence of these miRs) delays ORN differentiation and alters axon targeting in zebrafish.","method":"miRNA profiling; zebrafish miR-9/miR-200 depletion; Foxg1 mRNA quantification; reporter assays; Dlx5 null mouse olfactory epithelium analysis","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 — miRNA-mediated pathway downstream of Dlx5 identified by profiling and functional zebrafish experiments, multi-model","pmids":["25937343"],"is_preprint":false},{"year":2023,"finding":"DLX5 directly binds the Col10a1 cis-enhancer (confirmed by dual-luciferase and ChIP assays) and promotes Col10a1 expression and chondrocyte hypertrophy; DLX5 cooperates with RUNX2, as adjacent DLX5 and RUNX2 binding sites exist within the Col10a1 enhancer; DLX5 and COL10A1 are co-upregulated in a murine OA model.","method":"Dual-luciferase reporter assay; ChIP; siRNA knockdown and overexpression; murine OA model","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 1 — direct DNA binding confirmed by ChIP and reporter mutagenesis, single lab","pmids":["37492739"],"is_preprint":false},{"year":2018,"finding":"STAT5A negatively regulates Dlx5 expression in bone marrow-derived stromal cells; STAT5A deletion increases trabecular and cortical bone mass and enhances fracture healing by promoting osteogenesis, establishing a STAT5A-DLX5 regulatory axis in osteogenesis.","method":"STAT5A siRNA knockdown; STAT5A knockout mouse analysis (bone morphometry, fracture model); in vitro osteogenesis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with in vitro mechanistic data, single lab","pmids":["30429452"],"is_preprint":false},{"year":2018,"finding":"cAMP/PKA signaling inhibits Dlx5 expression in preadipocytes via CREB-mediated induction of C/EBPβ, which directly binds site-1 (−517 to −510 bp) in the Dlx5 promoter to suppress transcription; C/EBPβ knockdown rescues Dlx5 expression in IBMX-treated cells.","method":"Luciferase reporter assay; ChIP; siRNA knockdown (C/EBPβ); forced CREB and C/EBPβ expression","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 — ChIP confirms direct binding site, knockdown rescue confirms epistasis, single lab","pmids":["30322210"],"is_preprint":false},{"year":2010,"finding":"DLX5 directly binds and activates the NOTCH1 promoter (identified by JASPAR analysis and confirmed by dual-luciferase reporter assay), and knockdown of DLX5 reduces NOTCH1, NICD, and HES1 expression; NOTCH1 overexpression rescues proliferation and migration inhibition caused by DLX5 knockdown in osteosarcoma cells.","method":"Dual-luciferase reporter assay; siRNA knockdown; NOTCH1 overexpression rescue; xenograft model","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay with rescue experiment establishes DLX5-NOTCH1 pathway, single lab","pmids":["34249467"],"is_preprint":false},{"year":2006,"finding":"Dlx5 and Dlx6 control vestibular cell fate specification by restricting Pax2 and activating Gbx2 and Bmp4 expression domains in the otic epithelium; otic induction initiates normally in Dlx5/6 null embryos but dorsal otic derivatives fail to form.","method":"Dlx5/6 double knockout mouse analysis; in situ hybridization for Pax2, Gbx2, Bmp4","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 — KO with identification of specific downstream molecular targets, replicated across multiple KO studies","pmids":["16900517"],"is_preprint":false},{"year":2011,"finding":"Dlx5 and Dlx6 are required for uterine adenogenesis; conditional inactivation of Dlx5/6 in the endometrium (using Pgr-Cre) results in sterility, very few uterine glands, and reduced expression of Foxa2 and Msx1, demonstrating a role for Dlx5/6 in gland formation and epithelial remodeling.","method":"Conditional knockout (Pgr-Cre; Dlx5/6 flox); uterine histology; gene expression analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — tissue-specific conditional KO with defined downstream targets, single lab","pmids":["26512061"],"is_preprint":false},{"year":2000,"finding":"A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is bound and activated by DLX proteins (confirmed by cotransfection and DNA-protein binding assays); this enhancer drives forebrain expression of transgenes recapitulating Dlx5/6 patterns, and its activity is drastically reduced in Dlx1/2 double mutant mice, establishing Dlx1/2-mediated cross-regulation of Dlx5/6 in the forebrain.","method":"Transgenic reporter assay (mouse and zebrafish); Dlx1/2 double mutant analysis; cotransfection reporter assay; DNA-protein binding assay (EMSA)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — EMSA and transgenic reporter with null mouse validation establish cross-regulatory mechanism","pmids":["10632600"],"is_preprint":false},{"year":2010,"finding":"A single nucleotide polymorphism (SNP) found in an autistic proband within the I56i ultraconserved enhancer of Dlx5/Dlx6 reduces DLX protein binding affinity (confirmed by binding assay) and decreases enhancer activity predominantly in the medial and caudal ganglionic eminences; Gtf2i (deleted in Williams-Beuren syndrome) is identified as a novel regulator of Dlx gene expression by affinity purification using the I56i sequence.","method":"Transgenic reporter assay; in vitro protein-binding assay; affinity purification/mass spectrometry","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assay and binding assay with novel protein identification by AP-MS, single lab","pmids":["20702565"],"is_preprint":false},{"year":2010,"finding":"Dlx5 and Dlx6 are required for development of parvalbumin-expressing cortical interneurons; loss of Dlx5 or Dlx5/6 preferentially reduces mature parvalbumin+ interneurons, increases their dendritic branching, and is associated with reduced CXCR4 expression and defective tangential migration; Dlx5/6+/- mice show spontaneous electrographic seizures and reduced gamma oscillations.","method":"Dlx5 and Dlx5/6 conditional knockout; interneuron transplantation assay; EEG recording; immunohistochemistry; migration analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — KO combined with transplantation assay establishes cell-autonomous requirement; EEG provides functional readout","pmids":["20392955"],"is_preprint":false},{"year":2019,"finding":"GABAergic neuron-specific inactivation of Dlx5/6 (using Vgat-Cre) reduces anxiety-like behaviors and obsessive-compulsive activities and results in 33% longer median lifespan; 20-month-old mutants show 25% body weight reduction with marked reduction of white and brown adipose tissue, implicating GABAergic Dlx5/6 signaling in metabolic regulation and longevity.","method":"Conditional knockout (Vgat-Cre; Dlx5/6 flox); behavioral testing; body composition analysis; survival analysis","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — GABAergic-specific conditional KO with defined behavioral and metabolic phenotypes, single lab","pmids":["31514171"],"is_preprint":false}],"current_model":"DLX5 is a homeodomain transcription factor that functions downstream of BMP signaling to directly bind homeodomain-response elements in target gene promoters/enhancers (including Runx2-P1, Osterix, ALP, MYC, IRS-2, NOTCH1, Col10a1, and FGF8), driving osteoblast and chondrocyte differentiation; its activity is modulated by physical interaction with MSX2 (mutual antagonism), by binding co-regulators Dlxin-1 and Praja1 (which controls Dlxin-1 stability via ubiquitin-proteasome degradation), and by post-translational phosphorylation by p38 MAPK (at Ser-34/Ser-217) and CaMKII (increasing protein stability and transactivation); in the brain, DLX5 is regulated by a MeCP2-mediated silent chromatin loop and participates in cross-regulatory Dlx cascades required for GABAergic interneuron development and function."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that DLX5 physically interacts with MSX2 through homeodomain regions and antagonizes MSX2-mediated transcriptional repression resolved how two competing homeodomain factors calibrate osteocalcin gene expression.","evidence":"Far-Western blot, EMSA, structure-function deletion analysis, and luciferase reporter assay in osteoblastic cells","pmids":["9819228"],"confidence":"High","gaps":["Whether DLX5–MSX2 antagonism operates genome-wide or only at select promoters","No structural model of the DLX5–MSX2 dimer"]},{"year":1999,"claim":"Dlx5 knockout mice revealed that this gene is required for craniofacial patterning, vestibular organ morphogenesis, and osteoblast differentiation in vivo, establishing its non-redundant developmental roles.","evidence":"Targeted gene knockout replacing exons I and II with lacZ; phenotypic analysis of homozygous mutant mice in two independent studies","pmids":["10433909","10433912"],"confidence":"High","gaps":["Functional redundancy with Dlx6 not resolved by single knockout","Downstream transcriptional targets not yet identified"]},{"year":1999,"claim":"Demonstrating that Dlx5 is a direct BMP-2/4-inducible gene that promotes osteoblast differentiation upon overexpression positioned it as a key effector downstream of BMP signaling in the osteogenic cascade.","evidence":"BMP-inducible gene isolation and stable overexpression in MC3T3-E1 cells with ALP, osteocalcin, and mineralization readouts","pmids":["10075846"],"confidence":"High","gaps":["Whether Dlx5 is sufficient or merely necessary for BMP-induced osteogenesis","Direct promoter targets of DLX5 not yet mapped"]},{"year":2000,"claim":"Identification of a conserved Dlx5/Dlx6 intergenic enhancer bound and activated by DLX1/2 proteins established the cross-regulatory cascade by which Dlx1/2 control Dlx5/6 forebrain expression.","evidence":"Transgenic reporter mice and zebrafish; Dlx1/2 double mutant analysis; EMSA and cotransfection reporter assays","pmids":["10632600"],"confidence":"High","gaps":["Identity of all trans-acting factors at this enhancer","Whether this cascade operates in non-forebrain tissues"]},{"year":2002,"claim":"Discovery that Dlxin-1 directly binds and coactivates DLX5, and that the E3 ligase Praja1 controls Dlxin-1 levels via ubiquitin-proteasome degradation, revealed a protein-level regulatory circuit tuning DLX5 transcriptional output.","evidence":"Yeast two-hybrid, GST pulldown, Co-IP, in vivo ubiquitination assay, RING mutant, proteasome inhibitor rescue, GAL4 reporter","pmids":["11084035","11959851"],"confidence":"High","gaps":["Physiological tissues and conditions where Praja1-Dlxin-1 axis regulates DLX5 in vivo","Whether other DLX family members are similarly regulated"]},{"year":2002,"claim":"Dlx5/Dlx6 double knockouts showed homeotic jaw transformation, split-hand/foot malformation rescued by AER-specific Dlx5, and vestibular defects, demonstrating that the two genes together specify mandibular identity, limb outgrowth, and inner ear patterning.","evidence":"Double knockout mice; tissue-specific transgenic rescue; in situ hybridization for downstream targets (BMP4, Pax2, Gbx2)","pmids":["12434331","12000792","12142028"],"confidence":"High","gaps":["Degree of functional equivalence between Dlx5 and Dlx6","Direct enhancer targets mediating limb outgrowth not mapped"]},{"year":2003,"claim":"Epistasis experiments showed DLX5 is indispensable for BMP-2-induced expression of both Runx2 and Osterix, with Osterix induction independent of Runx2, establishing DLX5 as a branching node in the osteogenic transcription factor hierarchy.","evidence":"Antisense knockdown of Dlx5; BMP-2 treatment in Runx2-null cells; cycloheximide treatment in C2C12 cells","pmids":["12815054","12963046"],"confidence":"High","gaps":["Whether DLX5 binds Osterix and Runx2 promoters directly (resolved later)","In vivo validation of linear pathway"]},{"year":2004,"claim":"Direct DNA binding of DLX5 to the alkaline phosphatase promoter and temporal ChIP analysis of osteocalcin chromatin occupancy demonstrated that DLX5 functions as a direct transcriptional activator that replaces MSX2 at target promoters during osteoblast maturation.","evidence":"EMSA, site-directed mutagenesis, ChIP time-course in differentiating osteoblasts, Runx2-null cell experiments","pmids":["15383550","15456894"],"confidence":"High","gaps":["Global set of direct DLX5 target promoters not yet defined","Mechanism of MSX2-to-DLX5 switch unclear"]},{"year":2004,"claim":"MeCP2-mediated formation of a silent chromatin loop at the Dlx5/Dlx6 locus in mouse brain, lost upon MeCP2 deletion, linked Rett syndrome pathology to DLX5 de-repression and provided a paradigm for epigenetic regulation of homeodomain gene clusters.","evidence":"ChIP, chromatin loop assay (ChIP-loop), Mecp2-null mouse brains, allele-specific expression analysis","pmids":["15608638"],"confidence":"High","gaps":["Whether Dlx5 de-repression causally contributes to Rett syndrome phenotypes","Whether the loop is cell-type specific within brain"]},{"year":2005,"claim":"Mapping of three homeodomain-response elements in the Runx2-P1 promoter directly bound and transactivated by DLX5 (and antagonized by MSX2) confirmed DLX5 as a direct upstream activator of Runx2 transcription.","evidence":"EMSA, site-directed mutagenesis of individual elements, promoter-reporter assay in C2C12 cells","pmids":["16115867"],"confidence":"High","gaps":["In vivo ChIP validation at endogenous Runx2 locus not yet performed"]},{"year":2007,"claim":"Demonstrating that p38 MAPK phosphorylates DLX5 at Ser-34 and Ser-217 to enhance its transactivation of the Osterix promoter revealed a key post-translational mechanism integrating MAPK signaling with the osteogenic transcription factor cascade.","evidence":"In vitro kinase assay, phosphosite mutagenesis, ChIP at Osterix promoter, BMP-2-stimulated osteoblasts","pmids":["18056716"],"confidence":"High","gaps":["Whether other kinases target these same sites in vivo","Crystal structure of phospho-DLX5 not available"]},{"year":2008,"claim":"Dlx5-null osteoblast analysis showed that DLX5 regulates the RANKL/OPG ratio, linking it to osteoblast-osteoclast coupling, while TGF-β receptor conditional knockouts demonstrated that TGF-β suppresses Dlx5 to maintain chondrogenic potential over osteogenic fate.","evidence":"Dlx5 null mouse femur analysis; co-culture osteoclastogenesis assay; compound Tgfbr2/Dlx5 conditional knockout rescue","pmids":["18669617","18684439"],"confidence":"High","gaps":["Whether DLX5 directly controls RANKL or OPG promoters","Full epistatic relationship between TGF-β and BMP at the Dlx5 promoter"]},{"year":2009,"claim":"Identification of MYC and IRS-2 as direct DLX5 transcriptional targets (confirmed by EMSA and ChIP) established pro-proliferative functions for DLX5 in cancer via MYC activation and IRS-2/AKT signaling, extending its role beyond developmental contexts.","evidence":"EMSA, ChIP, luciferase reporters, siRNA/shRNA knockdown with rescue by MYC or constitutively active AKT; xenograft tumor assays","pmids":["19497851","21045156"],"confidence":"High","gaps":["Whether DLX5 oncogenic functions depend on the same phosphorylation events as osteogenic functions","Prevalence of DLX5 activation across cancer types"]},{"year":2009,"claim":"CaMKII phosphorylation of DLX5 increases its protein stability and osteoblastogenic transactivation, adding a second kinase pathway that post-translationally amplifies DLX5 activity.","evidence":"In vitro kinase assay; protein stability assay; transcriptional reporter; KN-93 pharmacological inhibition","pmids":["19393622"],"confidence":"Medium","gaps":["Specific CaMKII phosphorylation sites on DLX5 not mapped","In vivo confirmation of CaMKII-DLX5 axis not provided"]},{"year":2010,"claim":"Dlx5/Dlx6 were shown to be required for parvalbumin-positive cortical interneuron development and tangential migration; heterozygous loss caused spontaneous seizures and impaired gamma oscillations, linking Dlx5/6 dosage to circuit-level function.","evidence":"Conditional knockout; interneuron transplantation assay; EEG recording; immunohistochemistry; CXCR4 expression analysis","pmids":["20392955"],"confidence":"High","gaps":["Direct transcriptional targets of DLX5 in interneurons not identified","Whether seizure phenotype is specifically due to parvalbumin+ neuron loss"]},{"year":2010,"claim":"Hand2 was identified as a negative-feedback regulator of Dlx5/6 in distal mandibular arch mesenchyme; failure to repress Dlx5/6 causes ectopic bone and aglossia, resolving how Dlx5/6 expression is spatially refined.","evidence":"Conditional knockout of Hand2; compound Hand2/Dlx5/6 mutants; in situ hybridization","pmids":["21558373"],"confidence":"High","gaps":["Whether Hand2 directly binds Dlx5/6 regulatory regions","Mechanism of Dlx5/6 repression by Hand2 unknown"]},{"year":2014,"claim":"In vivo ChIP and enhancer mutagenesis in transgenic mice demonstrated that DLX5 and MEF2 directly bind a conserved enhancer 30 kb upstream of Runx2, required for osteoblast-specific Runx2 expression, defining the cis-regulatory architecture of this key osteogenic locus.","evidence":"BAC reporter mouse; serial deletion and in vivo mutagenesis of binding sites; ChIP in primary osteoblasts; histone modification analysis","pmids":["24692107"],"confidence":"High","gaps":["Three-dimensional chromatin topology at the Runx2 locus not characterized","Whether this enhancer operates in chondrocytes"]},{"year":2019,"claim":"GABAergic-specific Dlx5/6 inactivation reduced anxiety, obsessive-compulsive behaviors, adiposity, and extended lifespan by 33%, revealing unexpected metabolic and longevity roles for Dlx5/6 in mature GABAergic circuits.","evidence":"Conditional knockout (Vgat-Cre; Dlx5/6 flox); behavioral testing; body composition and survival analysis","pmids":["31514171"],"confidence":"Medium","gaps":["Downstream metabolic effectors in GABAergic neurons not identified","Whether longevity effect is due to reduced adiposity or altered behavior","Independent replication needed"]},{"year":2021,"claim":"Genome-wide chromatin profiling revealed that DLX5 cooperates with TP63 at ~2000 enhancers in squamous cell carcinoma, with DLX5 reactivation driven by SOX2-mediated switching of its promoter from bivalent to active chromatin state.","evidence":"ATAC-seq, ChIP-seq, ELMER analysis, shRNA knockdown, xenograft assay in ESCC","pmids":["34370013"],"confidence":"Medium","gaps":["Direct physical interaction between DLX5 and TP63 not confirmed","Mechanism by which DLX5 selects enhancers genome-wide unclear"]},{"year":null,"claim":"Major unresolved questions include the complete set of direct DLX5 transcriptional targets in GABAergic interneurons, the structural basis for homeodomain-mediated partner interactions, and whether post-translational modifications that enhance osteogenic DLX5 activity also operate in neural or oncogenic contexts.","evidence":"","pmids":[],"confidence":"High","gaps":["No genome-wide direct target map (CUT&RUN/ChIP-seq) in interneurons","No crystal or cryo-EM structure of DLX5 homeodomain in complex with DNA or protein partners","Phosphorylation-site mapping in neural tissues not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,6,7,10,17,22,32,38]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,6,7,10,16,17,30,32,35]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,6,7,10,15,22]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,12,13,14,18,25,36,40]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,3,6,7,10,17,22,30,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,3,10,21,27]}],"complexes":[],"partners":["MSX2","RUNX2","DLXIN1","PRAJA1","DLX6","TP63","MEF2"],"other_free_text":[]},"mechanistic_narrative":"DLX5 is a homeodomain transcription factor that functions as a central integrator of skeletal patterning, osteoblast/chondrocyte differentiation, craniofacial morphogenesis, inner ear development, and GABAergic interneuron specification. In the osteogenic lineage, DLX5 acts as a BMP-2/4-inducible immediate-early gene that directly binds homeodomain-response elements in the promoters and enhancers of Runx2, Osterix, alkaline phosphatase, osteocalcin, and Col10a1 to drive differentiation; its transactivation is enhanced by p38 MAPK phosphorylation at Ser-34/Ser-217 and by CaMKII-mediated stabilization, while DLX5 antagonizes MSX2-mediated transcriptional repression through direct homeodomain–homeodomain interaction and competition for shared cis-elements [PMID:10075846, PMID:9819228, PMID:16115867, PMID:18056716, PMID:15383550]. Compound Dlx5/Dlx6 loss causes homeotic jaw transformation, split-hand/foot malformation, absent semicircular canals, and loss of parvalbumin-positive cortical interneurons with spontaneous seizures, establishing essential non-redundant roles in mandibular identity, limb outgrowth, vestibular morphogenesis, and forebrain GABAergic circuit assembly [PMID:12434331, PMID:12000792, PMID:12142028, PMID:20392955]. In cancer contexts, DLX5 directly activates MYC, IRS-2, and NOTCH1 transcription to promote proliferation via AKT and Notch signaling axes [PMID:19497851, PMID:21045156, PMID:34249467]."},"prefetch_data":{"uniprot":{"accession":"P56178","full_name":"Homeobox protein DLX-5","aliases":[],"length_aa":289,"mass_kda":31.5,"function":"Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. Binds to the homeodomain-response element of the ALPL and SP7 promoter. Binds to the MYC promoter. Requires the 5'-TAATTA-3' consensus sequence for DNA-binding","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P56178/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLX5","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLX5","total_profiled":1310},"omim":[{"mim_id":"621311","title":"DEVELOPMENTAL DYSPLASIA OF THE HIP 4; DDH4","url":"https://www.omim.org/entry/621311"},{"mim_id":"614464","title":"JOUBERT SYNDROME 15; JBTS15","url":"https://www.omim.org/entry/614464"},{"mim_id":"612351","title":"FORKHEAD BOX I3; FOXI3","url":"https://www.omim.org/entry/612351"},{"mim_id":"610523","title":"CENTROSOMAL PROTEIN, 41-KD; CEP41","url":"https://www.omim.org/entry/610523"},{"mim_id":"606359","title":"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A","url":"https://www.omim.org/entry/606359"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"endometrium 1","ntpm":13.2},{"tissue":"placenta","ntpm":11.0},{"tissue":"skin 1","ntpm":26.1}],"url":"https://www.proteinatlas.org/search/DLX5"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P56178","domains":[{"cath_id":"1.10.10.60","chopping":"145-197","consensus_level":"high","plddt":96.9904,"start":145,"end":197}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P56178","model_url":"https://alphafold.ebi.ac.uk/files/AF-P56178-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P56178-F1-predicted_aligned_error_v6.png","plddt_mean":60.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLX5","jax_strain_url":"https://www.jax.org/strain/search?query=DLX5"},"sequence":{"accession":"P56178","fasta_url":"https://rest.uniprot.org/uniprotkb/P56178.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P56178/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P56178"}},"corpus_meta":[{"pmid":"15608638","id":"PMC_15608638","title":"Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15608638","citation_count":438,"is_preprint":false},{"pmid":"10433909","id":"PMC_10433909","title":"Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10433909","citation_count":359,"is_preprint":false},{"pmid":"12815054","id":"PMC_12815054","title":"BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12815054","citation_count":348,"is_preprint":false},{"pmid":"12000792","id":"PMC_12000792","title":"The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12000792","citation_count":338,"is_preprint":false},{"pmid":"12963046","id":"PMC_12963046","title":"BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12963046","citation_count":327,"is_preprint":false},{"pmid":"10433912","id":"PMC_10433912","title":"Dlx5 regulates regional development of the branchial arches and sensory capsules.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10433912","citation_count":287,"is_preprint":false},{"pmid":"10632600","id":"PMC_10632600","title":"A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10632600","citation_count":276,"is_preprint":false},{"pmid":"10516593","id":"PMC_10516593","title":"DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiation.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10516593","citation_count":238,"is_preprint":false},{"pmid":"15456894","id":"PMC_15456894","title":"Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15456894","citation_count":229,"is_preprint":false},{"pmid":"18056716","id":"PMC_18056716","title":"BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18056716","citation_count":184,"is_preprint":false},{"pmid":"16115867","id":"PMC_16115867","title":"Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16115867","citation_count":171,"is_preprint":false},{"pmid":"15383550","id":"PMC_15383550","title":"Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15383550","citation_count":163,"is_preprint":false},{"pmid":"10075846","id":"PMC_10075846","title":"A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10075846","citation_count":161,"is_preprint":false},{"pmid":"12434331","id":"PMC_12434331","title":"Jaw transformation with gain of symmetry after Dlx5/Dlx6 inactivation: mirror of the past?","date":"2002","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12434331","citation_count":155,"is_preprint":false},{"pmid":"11683913","id":"PMC_11683913","title":"Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11683913","citation_count":148,"is_preprint":false},{"pmid":"20392955","id":"PMC_20392955","title":"Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20392955","citation_count":139,"is_preprint":false},{"pmid":"15223343","id":"PMC_15223343","title":"Segregation of lens and olfactory precursors from a common territory: cell sorting and reciprocity of Dlx5 and Pax6 expression.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15223343","citation_count":139,"is_preprint":false},{"pmid":"12812786","id":"PMC_12812786","title":"DLX5 positions the neural crest and preplacode region at the border of the neural plate.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12812786","citation_count":122,"is_preprint":false},{"pmid":"9819228","id":"PMC_9819228","title":"Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9819228","citation_count":120,"is_preprint":false},{"pmid":"12533617","id":"PMC_12533617","title":"DLX5 regulates development of peripheral and central components of the olfactory system.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12533617","citation_count":110,"is_preprint":false},{"pmid":"24692107","id":"PMC_24692107","title":"Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.","date":"2014","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/24692107","citation_count":101,"is_preprint":false},{"pmid":"21205918","id":"PMC_21205918","title":"Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.","date":"2010","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21205918","citation_count":100,"is_preprint":false},{"pmid":"11959851","id":"PMC_11959851","title":"A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11959851","citation_count":93,"is_preprint":false},{"pmid":"11084035","id":"PMC_11084035","title":"Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11084035","citation_count":92,"is_preprint":false},{"pmid":"8541214","id":"PMC_8541214","title":"The expression pattern of the Distal-less homeobox-containing gene Dlx-5 in the developing chick limb bud suggests its involvement in apical ectodermal ridge activity, pattern formation, and cartilage differentiation.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8541214","citation_count":92,"is_preprint":false},{"pmid":"9763476","id":"PMC_9763476","title":"An early phase of embryonic Dlx5 expression defines the rostral boundary of the neural plate.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9763476","citation_count":90,"is_preprint":false},{"pmid":"17335796","id":"PMC_17335796","title":"Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17335796","citation_count":89,"is_preprint":false},{"pmid":"18669617","id":"PMC_18669617","title":"Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18669617","citation_count":89,"is_preprint":false},{"pmid":"12142028","id":"PMC_12142028","title":"The Dlx5 homeobox gene is essential for vestibular morphogenesis in the mouse embryo through a BMP4-mediated pathway.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12142028","citation_count":86,"is_preprint":false},{"pmid":"21187071","id":"PMC_21187071","title":"AMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cells.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21187071","citation_count":78,"is_preprint":false},{"pmid":"12710966","id":"PMC_12710966","title":"BMP signals regulate Dlx5 during early avian skull development.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12710966","citation_count":74,"is_preprint":false},{"pmid":"21558373","id":"PMC_21558373","title":"Downregulation of Dlx5 and Dlx6 expression by Hand2 is essential for initiation of tongue morphogenesis.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21558373","citation_count":73,"is_preprint":false},{"pmid":"22121204","id":"PMC_22121204","title":"Identification of a novel DLX5 mutation in a family with autosomal recessive split hand and foot malformation.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22121204","citation_count":71,"is_preprint":false},{"pmid":"12054155","id":"PMC_12054155","title":"Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation.","date":"2002","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/12054155","citation_count":66,"is_preprint":false},{"pmid":"19934017","id":"PMC_19934017","title":"Indirect modulation of Shh signaling by Dlx5 affects the oral-nasal patterning of palate and rescues cleft palate in Msx1-null mice.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19934017","citation_count":65,"is_preprint":false},{"pmid":"12482714","id":"PMC_12482714","title":"Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12482714","citation_count":64,"is_preprint":false},{"pmid":"11599044","id":"PMC_11599044","title":"Distinct roles for Distal-less genes Dlx3 and Dlx5 in regulating ectodermal development in Xenopus.","date":"2001","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/11599044","citation_count":62,"is_preprint":false},{"pmid":"12727448","id":"PMC_12727448","title":"The Dlx5 homeodomain gene is essential for olfactory development and connectivity in the mouse.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/12727448","citation_count":61,"is_preprint":false},{"pmid":"20702565","id":"PMC_20702565","title":"An SNP in an ultraconserved regulatory element affects Dlx5/Dlx6 regulation in the forebrain.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702565","citation_count":58,"is_preprint":false},{"pmid":"28904069","id":"PMC_28904069","title":"Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker.","date":"2017","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/28904069","citation_count":57,"is_preprint":false},{"pmid":"16330189","id":"PMC_16330189","title":"Msx1 and Dlx5 act independently in development of craniofacial skeleton, but converge on the regulation of Bmp signaling in palate formation.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/16330189","citation_count":57,"is_preprint":false},{"pmid":"25870836","id":"PMC_25870836","title":"Different Methylation Patterns of RUNX2, OSX, DLX5 and BSP in Osteoblastic Differentiation of Mesenchymal Stem Cells.","date":"2015","source":"Cell journal","url":"https://pubmed.ncbi.nlm.nih.gov/25870836","citation_count":55,"is_preprint":false},{"pmid":"21045156","id":"PMC_21045156","title":"Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21045156","citation_count":51,"is_preprint":false},{"pmid":"18684439","id":"PMC_18684439","title":"TGF-beta mediated Dlx5 signaling plays a crucial role in osteo-chondroprogenitor cell lineage determination during mandible development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18684439","citation_count":50,"is_preprint":false},{"pmid":"22914741","id":"PMC_22914741","title":"Functional characterization of tissue-specific enhancers in the DLX5/6 locus.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22914741","citation_count":50,"is_preprint":false},{"pmid":"14962748","id":"PMC_14962748","title":"Defective neuronogenesis in the absence of Dlx5.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14962748","citation_count":49,"is_preprint":false},{"pmid":"25937343","id":"PMC_25937343","title":"The Dlx5 and Foxg1 transcription factors, linked via miRNA-9 and -200, are required for the development of the olfactory and GnRH system.","date":"2015","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/25937343","citation_count":48,"is_preprint":false},{"pmid":"16900517","id":"PMC_16900517","title":"Dlx5 and Dlx6 homeobox genes are required for specification of the mammalian vestibular apparatus.","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16900517","citation_count":45,"is_preprint":false},{"pmid":"17701895","id":"PMC_17701895","title":"DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17701895","citation_count":43,"is_preprint":false},{"pmid":"14654219","id":"PMC_14654219","title":"Msx1/Bmp4 genetic pathway regulates mammalian alveolar bone formation via induction of Dlx5 and Cbfa1.","date":"2003","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/14654219","citation_count":41,"is_preprint":false},{"pmid":"21108812","id":"PMC_21108812","title":"Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21108812","citation_count":40,"is_preprint":false},{"pmid":"12895028","id":"PMC_12895028","title":"Dlx5 regulates chondrocyte differentiation at multiple stages.","date":"2003","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12895028","citation_count":40,"is_preprint":false},{"pmid":"19497851","id":"PMC_19497851","title":"DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19497851","citation_count":38,"is_preprint":false},{"pmid":"31514171","id":"PMC_31514171","title":"Dlx5 and Dlx6 expression in GABAergic neurons controls behavior, metabolism, healthy aging and lifespan.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31514171","citation_count":36,"is_preprint":false},{"pmid":"19707792","id":"PMC_19707792","title":"Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35).","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19707792","citation_count":36,"is_preprint":false},{"pmid":"32631410","id":"PMC_32631410","title":"DLX5 and HOXC8 enhance the chondrogenic differentiation potential of stem cells from apical papilla via LINC01013.","date":"2020","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32631410","citation_count":36,"is_preprint":false},{"pmid":"28025541","id":"PMC_28025541","title":"miR-203 and miR-320 Regulate Bone Morphogenetic Protein-2-Induced Osteoblast Differentiation by Targeting Distal-Less Homeobox 5 (Dlx5).","date":"2016","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/28025541","citation_count":35,"is_preprint":false},{"pmid":"24459211","id":"PMC_24459211","title":"Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans.","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24459211","citation_count":35,"is_preprint":false},{"pmid":"24733577","id":"PMC_24733577","title":"MiR-124 inhibits myogenic differentiation of mesenchymal stem cells via targeting Dlx5.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24733577","citation_count":32,"is_preprint":false},{"pmid":"24569166","id":"PMC_24569166","title":"DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24569166","citation_count":32,"is_preprint":false},{"pmid":"15362572","id":"PMC_15362572","title":"Dlx5, the mouse homologue of the human-imprinted DLX5 gene, is biallelically expressed in the mouse brain.","date":"2004","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15362572","citation_count":31,"is_preprint":false},{"pmid":"12459268","id":"PMC_12459268","title":"An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12459268","citation_count":31,"is_preprint":false},{"pmid":"18316591","id":"PMC_18316591","title":"A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18316591","citation_count":30,"is_preprint":false},{"pmid":"27335460","id":"PMC_27335460","title":"Exclusion of Dlx5/6 expression from the distal-most mandibular arches enables BMP-mediated specification of the distal cap.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27335460","citation_count":30,"is_preprint":false},{"pmid":"32420617","id":"PMC_32420617","title":"LacZ-reporter mapping of Dlx5/6 expression and genoarchitectural analysis of the postnatal mouse prethalamus.","date":"2020","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32420617","citation_count":29,"is_preprint":false},{"pmid":"20824629","id":"PMC_20824629","title":"Msx1 and Dlx5 function synergistically to regulate frontal bone development.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/20824629","citation_count":29,"is_preprint":false},{"pmid":"24496061","id":"PMC_24496061","title":"Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformation.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24496061","citation_count":28,"is_preprint":false},{"pmid":"26512061","id":"PMC_26512061","title":"Dlx5 and Dlx6 control uterine adenogenesis during post-natal maturation: possible consequences for endometriosis.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26512061","citation_count":28,"is_preprint":false},{"pmid":"28982687","id":"PMC_28982687","title":"The Dlx5-FGF10 signaling cascade controls cranial neural crest and myoblast interaction during oropharyngeal patterning and development.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28982687","citation_count":27,"is_preprint":false},{"pmid":"14666512","id":"PMC_14666512","title":"Dlx5/6-enhancer directed expression of Cre recombinase in the pharyngeal arches and brain.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/14666512","citation_count":26,"is_preprint":false},{"pmid":"30429452","id":"PMC_30429452","title":"Inhibition of STAT5A promotes osteogenesis by DLX5 regulation.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30429452","citation_count":26,"is_preprint":false},{"pmid":"21227998","id":"PMC_21227998","title":"Identification of direct downstream targets of Dlx5 during early inner ear development.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21227998","citation_count":26,"is_preprint":false},{"pmid":"23382810","id":"PMC_23382810","title":"BMP-mediated functional cooperation between Dlx5;Dlx6 and Msx1;Msx2 during mammalian limb development.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23382810","citation_count":25,"is_preprint":false},{"pmid":"20014320","id":"PMC_20014320","title":"Polymethylmethacrylate particles impair osteoprogenitor viability and expression of osteogenic transcription factors Runx2, osterix, and Dlx5.","date":"2010","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/20014320","citation_count":25,"is_preprint":false},{"pmid":"10474161","id":"PMC_10474161","title":"Dlx-5 in limb initiation in the chick embryo.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10474161","citation_count":25,"is_preprint":false},{"pmid":"19195802","id":"PMC_19195802","title":"Expression analysis and mutation detection of DLX5 and DLX6 in autism.","date":"2009","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/19195802","citation_count":24,"is_preprint":false},{"pmid":"17027239","id":"PMC_17027239","title":"Dlx5- and Dlx6-mediated chondrogenesis: Differential domain requirements for a conserved function.","date":"2006","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/17027239","citation_count":23,"is_preprint":false},{"pmid":"18498429","id":"PMC_18498429","title":"Isolation and imprinting analysis of the porcine DLX5 gene and its association with carcass traits.","date":"2008","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18498429","citation_count":23,"is_preprint":false},{"pmid":"34370013","id":"PMC_34370013","title":"Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34370013","citation_count":22,"is_preprint":false},{"pmid":"27645561","id":"PMC_27645561","title":"Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27645561","citation_count":21,"is_preprint":false},{"pmid":"25332435","id":"PMC_25332435","title":"Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I.","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25332435","citation_count":21,"is_preprint":false},{"pmid":"33002480","id":"PMC_33002480","title":"RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33002480","citation_count":21,"is_preprint":false},{"pmid":"19956613","id":"PMC_19956613","title":"Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956613","citation_count":20,"is_preprint":false},{"pmid":"29670900","id":"PMC_29670900","title":"T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29670900","citation_count":20,"is_preprint":false},{"pmid":"19393622","id":"PMC_19393622","title":"Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19393622","citation_count":19,"is_preprint":false},{"pmid":"17969168","id":"PMC_17969168","title":"GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17969168","citation_count":19,"is_preprint":false},{"pmid":"37492739","id":"PMC_37492739","title":"DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression.","date":"2023","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37492739","citation_count":19,"is_preprint":false},{"pmid":"25467232","id":"PMC_25467232","title":"BRONJ-related jaw bone is associated with increased Dlx-5 and suppressed osteopontin-implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates.","date":"2014","source":"Clinical oral investigations","url":"https://pubmed.ncbi.nlm.nih.gov/25467232","citation_count":19,"is_preprint":false},{"pmid":"24682237","id":"PMC_24682237","title":"Expression of GAD67 and Dlx5 in the taste buds of mice genetically lacking Mash1.","date":"2014","source":"Chemical senses","url":"https://pubmed.ncbi.nlm.nih.gov/24682237","citation_count":18,"is_preprint":false},{"pmid":"25196357","id":"PMC_25196357","title":"Heterozygous DLX5 nonsense mutation associated with isolated split-hand/foot malformation with reduced penetrance and variable expressivity in two unrelated families.","date":"2014","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/25196357","citation_count":18,"is_preprint":false},{"pmid":"30657543","id":"PMC_30657543","title":"Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30657543","citation_count":18,"is_preprint":false},{"pmid":"29901112","id":"PMC_29901112","title":"miR‑339‑5p negatively regulates loureirin A‑induced hair follicle stem cell differentiation by targeting DLX5.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29901112","citation_count":18,"is_preprint":false},{"pmid":"10330497","id":"PMC_10330497","title":"Expression of DLX5 during human embryonic craniofacial development.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10330497","citation_count":18,"is_preprint":false},{"pmid":"29301908","id":"PMC_29301908","title":"Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice.","date":"2018","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29301908","citation_count":17,"is_preprint":false},{"pmid":"22342398","id":"PMC_22342398","title":"Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22342398","citation_count":17,"is_preprint":false},{"pmid":"23933587","id":"PMC_23933587","title":"Endothelin regulates neural crest deployment and fate to form great vessels through Dlx5/Dlx6-independent mechanisms.","date":"2013","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/23933587","citation_count":17,"is_preprint":false},{"pmid":"30322210","id":"PMC_30322210","title":"cAMP/Protein Kinase A Signaling Inhibits Dlx5 Expression via Activation of CREB and Subsequent C/EBPβ Induction in 3T3-L1 Preadipocytes.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30322210","citation_count":17,"is_preprint":false},{"pmid":"21505076","id":"PMC_21505076","title":"Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21505076","citation_count":17,"is_preprint":false},{"pmid":"34249467","id":"PMC_34249467","title":"DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34249467","citation_count":16,"is_preprint":false},{"pmid":"30297736","id":"PMC_30297736","title":"Probing the origin of matching functional jaws: roles of Dlx5/6 in cranial neural crest cells.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30297736","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51742,"output_tokens":10074,"usd":0.153168},"stage2":{"model":"claude-opus-4-6","input_tokens":14029,"output_tokens":4659,"usd":0.27993},"total_usd":0.433098,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Dlx5 null mice exhibit craniofacial abnormalities, vestibular malformations, and defective osteogenesis, establishing that Dlx5 is required for patterning of branchial arch derivatives, morphogenesis of the vestibular organ, and osteoblast differentiation in vivo.\",\n      \"method\": \"Targeted gene knockout (null allele replacing exons I and II with lacZ); phenotypic analysis of homozygous mutants\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined phenotypic readouts, replicated in two independent knockout studies (PMIDs 10433909 and 10433912)\",\n      \"pmids\": [\"10433909\", \"10433912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Dlx5 is a direct transcriptional target of BMP signaling (BMP-2 and BMP-4) in osteoblastic cells; overexpression of Dlx5 in MC3T3-E1 cells increases alkaline phosphatase activity, osteocalcin production, and mineralization, demonstrating a functional role in osteoblast differentiation downstream of BMP.\",\n      \"method\": \"BMP-inducible gene isolation; stable transfection overexpression assay; osteogenic marker measurement\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in osteoblasts with multiple orthogonal osteogenic readouts, replicated across multiple subsequent studies\",\n      \"pmids\": [\"10075846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"DLX5 and MSX2 form dimers via their homeodomain regions; DLX5 (residues 127–143) de-represses Msx2-mediated transcriptional repression of the osteocalcin promoter by antagonizing Msx2 binding and restoring OCFREB binding activity, without requiring its own intrinsic DNA-binding activity.\",\n      \"method\": \"Far-Western blot (protein-protein interaction); transient cotransfection/luciferase reporter assay; structure-function deletion analysis; EMSA\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (far-Western, EMSA, reporter assay, mutagenesis) in single rigorous study\",\n      \"pmids\": [\"9819228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DLX5 is an indispensable mediator of BMP-2-induced Runx2 expression in C2C12 cells; DLX5 is immediately induced by BMP-2 (cycloheximide-resistant), whereas Runx2 induction requires de novo protein synthesis. Antisense blocking of Dlx5 abolishes BMP-2-induced Runx2 expression. TGF-β1 opposes BMP-2-induced osteogenesis by suppressing Dlx5 expression through de novo AP-1 induction.\",\n      \"method\": \"Cycloheximide treatment; antisense knockdown; overexpression in C2C12 cells; osteogenic marker assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established by antisense blocking and overexpression with multiple markers, replicated across multiple subsequent studies\",\n      \"pmids\": [\"12815054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BMP-2-induced Osterix expression requires Dlx5 but not Runx2: Osx is still induced by BMP-2 in Runx2-null cells, but antisense blocking of Dlx5 completely abrogates BMP-2-induced Osx expression.\",\n      \"method\": \"Antisense Dlx5 knockdown; BMP-2 treatment in Runx2-null cells; gene expression analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established using null cells and antisense blocking, replicated in subsequent study (PMID 18056716)\",\n      \"pmids\": [\"12963046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DLX5 interferes with MSX2-Runx2 protein-protein interaction and relieves MSX2-mediated repression of Runx2 transcriptional activity; a missense mutation of MSX2 (P148H) associated with craniosynostosis retains ability to bind and repress Runx2, but is insensitive to DLX5 counter-regulation.\",\n      \"method\": \"Co-immunoprecipitation; transcriptional reporter assays; domain mapping\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein-protein interaction and functional data with disease-relevant mutant as control\",\n      \"pmids\": [\"11683913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DLX5 directly binds a cis-acting element in the alkaline phosphatase promoter (identified by EMSA and site-directed mutagenesis) and transactivates ALP expression; MSX2 competes with DLX5 for this same element to suppress ALP expression; DLX5-stimulated ALP activity is independent of Runx2.\",\n      \"method\": \"EMSA; site-directed mutagenesis; promoter-reporter assay; Runx2-null cell experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA-binding confirmed by EMSA and mutagenesis, functional independence from Runx2 shown in null cells\",\n      \"pmids\": [\"15383550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DLX5 specifically transactivates the Runx2 type II (P1 distal) promoter by binding to three homeodomain-response elements between −756 and −342 bp; this activity is confirmed by gel mobility shift assay and site-directed mutagenesis and is antagonized by MSX2 at the same region.\",\n      \"method\": \"Promoter deletion analysis; gel mobility shift assay (EMSA); site-directed mutagenesis; reporter assay; overexpression in C2C12 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA binding confirmed by EMSA and mutagenesis of specific response elements\",\n      \"pmids\": [\"16115867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dlxin-1 (MAGE/Necdin family protein) directly binds DLX5 (and DLX7 and MSX2) and activates DLX5-dependent transcription; interaction confirmed by yeast two-hybrid, GST pulldown, and co-immunoprecipitation.\",\n      \"method\": \"Yeast two-hybrid screening; GST pulldown; co-immunoprecipitation; reporter gene assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple methods (Y2H, pulldown, Co-IP, reporter) confirm binding and functional activation\",\n      \"pmids\": [\"11084035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The RING finger E3 ubiquitin ligase Praja1 binds the C-terminal necdin homology domain of Dlxin-1 and promotes its ubiquitin-dependent proteasomal degradation, thereby down-regulating DLX5-dependent transcriptional activity.\",\n      \"method\": \"Yeast two-hybrid; GST pulldown; co-immunoprecipitation; proteasome inhibitor rescue; in vivo ubiquitination assay; RING mutant; GAL4 reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted ubiquitination, mutagenesis of RING domain, proteasome inhibitor rescue, multiple orthogonal methods\",\n      \"pmids\": [\"11959851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DLX5 binds to homeodomain-response elements in the Osterix promoter (confirmed by EMSA and ChIP), and is phosphorylated by p38 MAPK at Ser-34 and Ser-217 in vitro and in vivo; this phosphorylation increases DLX5 transactivation potential and is required for full BMP-2-induced Osterix induction.\",\n      \"method\": \"EMSA; ChIP; in vitro kinase assay; site-directed mutagenesis (Ser-34/217); overexpression and knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation + mutagenesis + in vivo ChIP confirm direct mechanism\",\n      \"pmids\": [\"18056716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MeCP2 recruits histone deacetylase 1 (HDAC1) to the Dlx5-Dlx6 locus in mouse brain, promotes repressive H3K9 methylation at this ~1-kb region, and mediates formation of an 11-kb silent chromatin loop at the locus; loss of MeCP2 (in Mecp2-null mice) abolishes this loop and de-represses Dlx5-Dlx6 expression approximately two-fold.\",\n      \"method\": \"ChIP; chromatin loop assay (ChIP-loop); Mecp2-null mouse brains; allele-specific expression analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and loop assay in wild-type vs. null mice; novel mechanism validated by multiple chromatin methods\",\n      \"pmids\": [\"15608638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Combined inactivation of Dlx5 and Dlx6 in mice causes homeotic-like transformation of the lower jaw into an upper jaw (gain of symmetry), demonstrating that Dlx5/Dlx6 together specify mandibular/lower jaw identity in the first pharyngeal arch.\",\n      \"method\": \"Double knockout mice; skeletal phenotype analysis\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with strong morphological phenotype establishing homeotic function\",\n      \"pmids\": [\"12434331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Combined deletion of Dlx5 and Dlx6 in mice causes severe craniofacial, axial, and appendicular skeletal defects phenocopying split-hand/foot malformation (SHFM); transgenic overexpression of Dlx5 specifically in the apical ectodermal ridge fully rescues limb outgrowth in Dlx5/6 null mice, demonstrating that AER-expressed Dlx5 is sufficient for this function.\",\n      \"method\": \"Double knockout mice; tissue-specific transgenic rescue experiment\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue by tissue-specific transgene establishes tissue-autonomous requirement\",\n      \"pmids\": [\"12000792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Dlx5 homeobox gene is essential for vestibular morphogenesis through regulation of BMP4 expression: Dlx5 null mice lack semicircular canals and have severely reduced BMP4 expression in the otic vesicle, while Nkx5.1, Pax2, and Lfng expression is unchanged.\",\n      \"method\": \"Dlx5 null mouse analysis; in situ hybridization for downstream genes; comparative marker analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific downstream target (BMP4) identified by in situ hybridization\",\n      \"pmids\": [\"12142028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"During osteoblast differentiation, a temporal molecular switch occurs at the osteocalcin gene promoter: Msx2 occupies it in proliferating osteoblasts (repressing transcription), while Dlx3, Dlx5, and Runx2 are recruited post-proliferatively to activate transcription; Dlx5 occupancy increases over Dlx3 at the mineralization stage. Dlx3 and Runx2 directly interact (mapped to Runx2 residues 376–432).\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); co-immunoprecipitation; reporter assay; RNA interference knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ChIP-based temporal chromatin occupancy combined with protein-protein interaction and functional assays\",\n      \"pmids\": [\"15456894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLX5 directly binds the IRS-2 promoter (confirmed by ChIP and luciferase assay) and augments its transcription; DLX5-driven cell proliferation in ovarian cancer cells operates through the IRS-2-AKT signaling axis, as knockdown of IRS-2 and MET suppresses AKT phosphorylation downstream of DLX5.\",\n      \"method\": \"ChIP; luciferase reporter assay; shRNA stable knockdown; constitutively active AKT rescue; xenograft tumor growth assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct promoter binding confirmed by ChIP and mutagenesis, rescued by AKT overexpression\",\n      \"pmids\": [\"21045156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLX5 directly binds two sites in the MYC promoter (confirmed by EMSA and ChIP) and specifically activates MYC transcription in a dose-dependent manner; DLX5-mediated cell proliferation is rescued by MYC overexpression following DLX5 knockdown, placing MYC downstream of DLX5.\",\n      \"method\": \"Luciferase reporter assay; EMSA; ChIP; siRNA knockdown; MYC overexpression rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA binding confirmed by EMSA and ChIP, functional rescue confirms linear pathway\",\n      \"pmids\": [\"19497851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLX5 is a cell-autonomous regulator of chondrocyte hypertrophy during endochondral ossification: Col2a1-Dlx5 transgenic mice with chondrocyte-restricted Dlx5 expression show accelerated chondrocyte hypertrophy and mineralization, and this transgene specifically rescues the chondrocyte differentiation defects of Dlx5/6 null mice. Dlx5 and Dlx6 are functionally equivalent in this context.\",\n      \"method\": \"Chondrocyte-specific transgenic expression (Col2a1 promoter); rescue of Dlx5/6 null phenotype\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type specific transgene with null rescue establishes cell-autonomous function\",\n      \"pmids\": [\"19956613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dlx5 null osteoblasts show reduced expression of Runx2, Osterix, Osteocalcin, and Bone Sialoprotein; Dlx5(-/-) femurs have increased osteoclast numbers and Dlx5(-/-) osteoblasts show a higher RANKL/OPG ratio, inducing more TRAP-positive multinucleated osteoclast-like cells in co-culture. This establishes Dlx5 as a regulator of osteoblast-osteoclast coupling.\",\n      \"method\": \"Dlx5 null mouse embryo analysis; osteoblast culture; RANKL/OPG expression analysis; spleen cell co-culture osteoclastogenesis assay\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined molecular mechanism (RANKL/OPG ratio) and functional co-culture readout\",\n      \"pmids\": [\"18669617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CaMKII phosphorylates DLX5, increases its protein stability, and increases its osteoblastogenic transactivation activity; the CaMKII inhibitor KN-93 decreases osteogenic and transactivation activities of Dlx5.\",\n      \"method\": \"In vitro kinase assay; protein stability assay; transcriptional reporter assay; pharmacological inhibition\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro kinase assay with functional consequences, single lab\",\n      \"pmids\": [\"19393622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AMPK activation (via AICAR or metformin) stimulates osteoblast differentiation through Smad1/5/8 phosphorylation → Dlx5 expression → Runx2 expression; siRNA knockdown of Dlx5 suppresses metformin-induced Runx2 expression, placing Dlx5 downstream of AMPK/Smad signaling and upstream of Runx2.\",\n      \"method\": \"AMPK activator/inhibitor pharmacology; dominant-negative AMPK; siRNA knockdown; BRE-Luc and Runx2-Luc reporter assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placement via siRNA epistasis, single lab\",\n      \"pmids\": [\"21187071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dlx5 and Mef2 directly bind to a conserved 343-bp osteoblast-specific enhancer ~30 kb upstream of the Runx2 distal promoter (confirmed by ChIP); their binding sites are required for osteoblast-specific Runx2 expression in mice; other factors (Tcf7, Ctnnb1, Sp7, Smad1, Sox6) bind through protein-protein interactions.\",\n      \"method\": \"BAC reporter mouse; serial deletion; ChIP in primary osteoblasts; histone modification analysis; enhancer binding site mutagenesis in vivo\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct ChIP binding and in vivo mutagenesis of binding sites in transgenic mice\",\n      \"pmids\": [\"24692107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DLX5 is a direct transcriptional target of the FGF8 locus and participates in a regulatory loop with p63 and Pin1: DLX5 activates FGF8 expression, while FGF8 counteracts Pin1-ΔNp63α interaction; Pin1 negatively regulates ΔNp63α protein stability via proteasomal degradation; p63 mutants associated with SHFM/EEC are resistant to Pin1 action.\",\n      \"method\": \"In vivo ChIP; luciferase reporter; co-immunoprecipitation; proteasome assay; mouse embryo analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — regulatory loop established with ChIP and functional assays, single lab\",\n      \"pmids\": [\"24569166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dlx5 identifies direct target genes in the inner ear by gene expression profiling of wild-type vs. Dlx5-null otic vesicles; ChIP confirms DLX5 directly binds promoters of Atbf1, Bmper, Large, Lrrtm1, Msx1, Ebf1, and Lhx1, with Bmper and Lrrtm1 being up-regulated upon Dlx5 overexpression, supporting BMP signaling as downstream of Dlx5 in the inner ear.\",\n      \"method\": \"Gene expression profiling (microarray); ChIP with Dlx5 antibody in overexpressing cell line; motif analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirms direct binding to multiple promoters, supported by expression data\",\n      \"pmids\": [\"21227998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Hand2 represses Dlx5 and Dlx6 expression in the distal mandibular arch ectomesenchyme as part of a negative-feedback loop (Dlx5/6 first induce Hand2, which then represses Dlx5/6); failure to repress Dlx5/6 leads to upregulation of Runx2 and aberrant bone formation, and aglossia due to absent lateral lingual swelling.\",\n      \"method\": \"Conditional knockout mouse; genetic epistasis (Hand2 and Dlx5/6 compound mutants); in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in compound mutants with mechanistic pathway placement\",\n      \"pmids\": [\"21558373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dlx5 loss leads to reduced Fgf7 expression and expanded Shh signaling in the palatal mesenchyme; this expanded Shh signaling rescues palatal expansion and fusion in Msx1-null mice. Exogenous Fgf7 inhibits Shh signaling and reverses this rescue in Msx1/Dlx5 double knockout palates.\",\n      \"method\": \"Dlx5 null and Msx1/Dlx5 double-KO mouse analysis; exogenous Fgf7 treatment; in situ hybridization; genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (double KO rescue) with exogenous factor reversal confirms pathway\",\n      \"pmids\": [\"19934017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TGF-β signaling in cranial neural crest cells suppresses Dlx5 expression and maintains chondrogenic potential; conditional inactivation of Tgfbr2 in CNC cells leads to elevated Dlx5 expression and accelerated osteoprogenitor differentiation at the expense of chondrogenesis; deletion of Dlx5 in Tgfbr2 CNC conditional knockout mice rescues cartilage formation in the angular processes.\",\n      \"method\": \"Conditional knockout (Tgfbr2flox; Wnt1-Cre); Dlx5/Tgfbr2 compound conditional KO rescue; in situ hybridization; exogenous TGF-β treatment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — compound conditional KO rescue definitively places Dlx5 downstream of TGF-β signaling in osteo-chondrogenic lineage determination\",\n      \"pmids\": [\"18684439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Dlx5 in cranial neural crest cells controls FGF10 signaling to regulate interaction between CNC-derived cells and pharyngeal mesoderm-derived myoblasts during soft palate development; FGF10 pathway is downregulated in Dlx5 null mice and exogenous FGF10 rescues CNC cell proliferation and myogenic differentiation.\",\n      \"method\": \"Dlx5 null mouse analysis; exogenous FGF10 rescue; CNC-myoblast interaction analysis; proliferation and apoptosis assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype with ligand rescue identifies downstream pathway, single lab\",\n      \"pmids\": [\"28982687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DLX5 and DLX6 reciprocally inhibit BMP/HAND2-mediated activation of the Hand1 enhancer in the mandibular arch distal cap; DLX5/DLX6 homeodomain proteins thus exclude formation of the Hand1-positive distal cap domain from Dlx5/6-expressing proximal domains.\",\n      \"method\": \"Enhancer reporter assay; co-transfection with DLX5/6; genetic analysis in Dlx5/6 null embryos\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay with DLX5/6 and null embryo validation, single lab\",\n      \"pmids\": [\"27335460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DLX5 cooperates with the master transcription factor TP63 in regulating approximately 2000 enhancers and promoters in squamous cell carcinoma; DLX5 promoter gains active histone marks via SOX2-mediated activation in ESCC (vs. bivalent/silenced state in normal tissue); DLX5 silencing inhibits SCC viability in vitro and in vivo.\",\n      \"method\": \"ATAC-seq/ChIP-seq (bivalent chromatin analysis); computational ELMER analysis; shRNA knockdown; xenograft assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple chromatin methods establishing co-regulatory mechanism, single lab\",\n      \"pmids\": [\"34370013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dlx5 regulates olfactory receptor neuron differentiation via miR-9 and miR-200 class microRNAs; Dlx5 null olfactory epithelium has reduced miR-9, miR-376a, and miR-200 class expression; miR-9 and miR-200 negatively regulate Foxg1 mRNA, and elevated Foxg1 (in the absence of these miRs) delays ORN differentiation and alters axon targeting in zebrafish.\",\n      \"method\": \"miRNA profiling; zebrafish miR-9/miR-200 depletion; Foxg1 mRNA quantification; reporter assays; Dlx5 null mouse olfactory epithelium analysis\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — miRNA-mediated pathway downstream of Dlx5 identified by profiling and functional zebrafish experiments, multi-model\",\n      \"pmids\": [\"25937343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DLX5 directly binds the Col10a1 cis-enhancer (confirmed by dual-luciferase and ChIP assays) and promotes Col10a1 expression and chondrocyte hypertrophy; DLX5 cooperates with RUNX2, as adjacent DLX5 and RUNX2 binding sites exist within the Col10a1 enhancer; DLX5 and COL10A1 are co-upregulated in a murine OA model.\",\n      \"method\": \"Dual-luciferase reporter assay; ChIP; siRNA knockdown and overexpression; murine OA model\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct DNA binding confirmed by ChIP and reporter mutagenesis, single lab\",\n      \"pmids\": [\"37492739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"STAT5A negatively regulates Dlx5 expression in bone marrow-derived stromal cells; STAT5A deletion increases trabecular and cortical bone mass and enhances fracture healing by promoting osteogenesis, establishing a STAT5A-DLX5 regulatory axis in osteogenesis.\",\n      \"method\": \"STAT5A siRNA knockdown; STAT5A knockout mouse analysis (bone morphometry, fracture model); in vitro osteogenesis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with in vitro mechanistic data, single lab\",\n      \"pmids\": [\"30429452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"cAMP/PKA signaling inhibits Dlx5 expression in preadipocytes via CREB-mediated induction of C/EBPβ, which directly binds site-1 (−517 to −510 bp) in the Dlx5 promoter to suppress transcription; C/EBPβ knockdown rescues Dlx5 expression in IBMX-treated cells.\",\n      \"method\": \"Luciferase reporter assay; ChIP; siRNA knockdown (C/EBPβ); forced CREB and C/EBPβ expression\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — ChIP confirms direct binding site, knockdown rescue confirms epistasis, single lab\",\n      \"pmids\": [\"30322210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DLX5 directly binds and activates the NOTCH1 promoter (identified by JASPAR analysis and confirmed by dual-luciferase reporter assay), and knockdown of DLX5 reduces NOTCH1, NICD, and HES1 expression; NOTCH1 overexpression rescues proliferation and migration inhibition caused by DLX5 knockdown in osteosarcoma cells.\",\n      \"method\": \"Dual-luciferase reporter assay; siRNA knockdown; NOTCH1 overexpression rescue; xenograft model\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay with rescue experiment establishes DLX5-NOTCH1 pathway, single lab\",\n      \"pmids\": [\"34249467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dlx5 and Dlx6 control vestibular cell fate specification by restricting Pax2 and activating Gbx2 and Bmp4 expression domains in the otic epithelium; otic induction initiates normally in Dlx5/6 null embryos but dorsal otic derivatives fail to form.\",\n      \"method\": \"Dlx5/6 double knockout mouse analysis; in situ hybridization for Pax2, Gbx2, Bmp4\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with identification of specific downstream molecular targets, replicated across multiple KO studies\",\n      \"pmids\": [\"16900517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dlx5 and Dlx6 are required for uterine adenogenesis; conditional inactivation of Dlx5/6 in the endometrium (using Pgr-Cre) results in sterility, very few uterine glands, and reduced expression of Foxa2 and Msx1, demonstrating a role for Dlx5/6 in gland formation and epithelial remodeling.\",\n      \"method\": \"Conditional knockout (Pgr-Cre; Dlx5/6 flox); uterine histology; gene expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific conditional KO with defined downstream targets, single lab\",\n      \"pmids\": [\"26512061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is bound and activated by DLX proteins (confirmed by cotransfection and DNA-protein binding assays); this enhancer drives forebrain expression of transgenes recapitulating Dlx5/6 patterns, and its activity is drastically reduced in Dlx1/2 double mutant mice, establishing Dlx1/2-mediated cross-regulation of Dlx5/6 in the forebrain.\",\n      \"method\": \"Transgenic reporter assay (mouse and zebrafish); Dlx1/2 double mutant analysis; cotransfection reporter assay; DNA-protein binding assay (EMSA)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and transgenic reporter with null mouse validation establish cross-regulatory mechanism\",\n      \"pmids\": [\"10632600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A single nucleotide polymorphism (SNP) found in an autistic proband within the I56i ultraconserved enhancer of Dlx5/Dlx6 reduces DLX protein binding affinity (confirmed by binding assay) and decreases enhancer activity predominantly in the medial and caudal ganglionic eminences; Gtf2i (deleted in Williams-Beuren syndrome) is identified as a novel regulator of Dlx gene expression by affinity purification using the I56i sequence.\",\n      \"method\": \"Transgenic reporter assay; in vitro protein-binding assay; affinity purification/mass spectrometry\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assay and binding assay with novel protein identification by AP-MS, single lab\",\n      \"pmids\": [\"20702565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dlx5 and Dlx6 are required for development of parvalbumin-expressing cortical interneurons; loss of Dlx5 or Dlx5/6 preferentially reduces mature parvalbumin+ interneurons, increases their dendritic branching, and is associated with reduced CXCR4 expression and defective tangential migration; Dlx5/6+/- mice show spontaneous electrographic seizures and reduced gamma oscillations.\",\n      \"method\": \"Dlx5 and Dlx5/6 conditional knockout; interneuron transplantation assay; EEG recording; immunohistochemistry; migration analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO combined with transplantation assay establishes cell-autonomous requirement; EEG provides functional readout\",\n      \"pmids\": [\"20392955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GABAergic neuron-specific inactivation of Dlx5/6 (using Vgat-Cre) reduces anxiety-like behaviors and obsessive-compulsive activities and results in 33% longer median lifespan; 20-month-old mutants show 25% body weight reduction with marked reduction of white and brown adipose tissue, implicating GABAergic Dlx5/6 signaling in metabolic regulation and longevity.\",\n      \"method\": \"Conditional knockout (Vgat-Cre; Dlx5/6 flox); behavioral testing; body composition analysis; survival analysis\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — GABAergic-specific conditional KO with defined behavioral and metabolic phenotypes, single lab\",\n      \"pmids\": [\"31514171\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLX5 is a homeodomain transcription factor that functions downstream of BMP signaling to directly bind homeodomain-response elements in target gene promoters/enhancers (including Runx2-P1, Osterix, ALP, MYC, IRS-2, NOTCH1, Col10a1, and FGF8), driving osteoblast and chondrocyte differentiation; its activity is modulated by physical interaction with MSX2 (mutual antagonism), by binding co-regulators Dlxin-1 and Praja1 (which controls Dlxin-1 stability via ubiquitin-proteasome degradation), and by post-translational phosphorylation by p38 MAPK (at Ser-34/Ser-217) and CaMKII (increasing protein stability and transactivation); in the brain, DLX5 is regulated by a MeCP2-mediated silent chromatin loop and participates in cross-regulatory Dlx cascades required for GABAergic interneuron development and function.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DLX5 is a homeodomain transcription factor that functions as a central integrator of skeletal patterning, osteoblast/chondrocyte differentiation, craniofacial morphogenesis, inner ear development, and GABAergic interneuron specification. In the osteogenic lineage, DLX5 acts as a BMP-2/4-inducible immediate-early gene that directly binds homeodomain-response elements in the promoters and enhancers of Runx2, Osterix, alkaline phosphatase, osteocalcin, and Col10a1 to drive differentiation; its transactivation is enhanced by p38 MAPK phosphorylation at Ser-34/Ser-217 and by CaMKII-mediated stabilization, while DLX5 antagonizes MSX2-mediated transcriptional repression through direct homeodomain–homeodomain interaction and competition for shared cis-elements [PMID:10075846, PMID:9819228, PMID:16115867, PMID:18056716, PMID:15383550]. Compound Dlx5/Dlx6 loss causes homeotic jaw transformation, split-hand/foot malformation, absent semicircular canals, and loss of parvalbumin-positive cortical interneurons with spontaneous seizures, establishing essential non-redundant roles in mandibular identity, limb outgrowth, vestibular morphogenesis, and forebrain GABAergic circuit assembly [PMID:12434331, PMID:12000792, PMID:12142028, PMID:20392955]. In cancer contexts, DLX5 directly activates MYC, IRS-2, and NOTCH1 transcription to promote proliferation via AKT and Notch signaling axes [PMID:19497851, PMID:21045156, PMID:34249467].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that DLX5 physically interacts with MSX2 through homeodomain regions and antagonizes MSX2-mediated transcriptional repression resolved how two competing homeodomain factors calibrate osteocalcin gene expression.\",\n      \"evidence\": \"Far-Western blot, EMSA, structure-function deletion analysis, and luciferase reporter assay in osteoblastic cells\",\n      \"pmids\": [\"9819228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX5–MSX2 antagonism operates genome-wide or only at select promoters\", \"No structural model of the DLX5–MSX2 dimer\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Dlx5 knockout mice revealed that this gene is required for craniofacial patterning, vestibular organ morphogenesis, and osteoblast differentiation in vivo, establishing its non-redundant developmental roles.\",\n      \"evidence\": \"Targeted gene knockout replacing exons I and II with lacZ; phenotypic analysis of homozygous mutant mice in two independent studies\",\n      \"pmids\": [\"10433909\", \"10433912\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy with Dlx6 not resolved by single knockout\", \"Downstream transcriptional targets not yet identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that Dlx5 is a direct BMP-2/4-inducible gene that promotes osteoblast differentiation upon overexpression positioned it as a key effector downstream of BMP signaling in the osteogenic cascade.\",\n      \"evidence\": \"BMP-inducible gene isolation and stable overexpression in MC3T3-E1 cells with ALP, osteocalcin, and mineralization readouts\",\n      \"pmids\": [\"10075846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Dlx5 is sufficient or merely necessary for BMP-induced osteogenesis\", \"Direct promoter targets of DLX5 not yet mapped\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of a conserved Dlx5/Dlx6 intergenic enhancer bound and activated by DLX1/2 proteins established the cross-regulatory cascade by which Dlx1/2 control Dlx5/6 forebrain expression.\",\n      \"evidence\": \"Transgenic reporter mice and zebrafish; Dlx1/2 double mutant analysis; EMSA and cotransfection reporter assays\",\n      \"pmids\": [\"10632600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of all trans-acting factors at this enhancer\", \"Whether this cascade operates in non-forebrain tissues\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that Dlxin-1 directly binds and coactivates DLX5, and that the E3 ligase Praja1 controls Dlxin-1 levels via ubiquitin-proteasome degradation, revealed a protein-level regulatory circuit tuning DLX5 transcriptional output.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, Co-IP, in vivo ubiquitination assay, RING mutant, proteasome inhibitor rescue, GAL4 reporter\",\n      \"pmids\": [\"11084035\", \"11959851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological tissues and conditions where Praja1-Dlxin-1 axis regulates DLX5 in vivo\", \"Whether other DLX family members are similarly regulated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Dlx5/Dlx6 double knockouts showed homeotic jaw transformation, split-hand/foot malformation rescued by AER-specific Dlx5, and vestibular defects, demonstrating that the two genes together specify mandibular identity, limb outgrowth, and inner ear patterning.\",\n      \"evidence\": \"Double knockout mice; tissue-specific transgenic rescue; in situ hybridization for downstream targets (BMP4, Pax2, Gbx2)\",\n      \"pmids\": [\"12434331\", \"12000792\", \"12142028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degree of functional equivalence between Dlx5 and Dlx6\", \"Direct enhancer targets mediating limb outgrowth not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Epistasis experiments showed DLX5 is indispensable for BMP-2-induced expression of both Runx2 and Osterix, with Osterix induction independent of Runx2, establishing DLX5 as a branching node in the osteogenic transcription factor hierarchy.\",\n      \"evidence\": \"Antisense knockdown of Dlx5; BMP-2 treatment in Runx2-null cells; cycloheximide treatment in C2C12 cells\",\n      \"pmids\": [\"12815054\", \"12963046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX5 binds Osterix and Runx2 promoters directly (resolved later)\", \"In vivo validation of linear pathway\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Direct DNA binding of DLX5 to the alkaline phosphatase promoter and temporal ChIP analysis of osteocalcin chromatin occupancy demonstrated that DLX5 functions as a direct transcriptional activator that replaces MSX2 at target promoters during osteoblast maturation.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis, ChIP time-course in differentiating osteoblasts, Runx2-null cell experiments\",\n      \"pmids\": [\"15383550\", \"15456894\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Global set of direct DLX5 target promoters not yet defined\", \"Mechanism of MSX2-to-DLX5 switch unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"MeCP2-mediated formation of a silent chromatin loop at the Dlx5/Dlx6 locus in mouse brain, lost upon MeCP2 deletion, linked Rett syndrome pathology to DLX5 de-repression and provided a paradigm for epigenetic regulation of homeodomain gene clusters.\",\n      \"evidence\": \"ChIP, chromatin loop assay (ChIP-loop), Mecp2-null mouse brains, allele-specific expression analysis\",\n      \"pmids\": [\"15608638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Dlx5 de-repression causally contributes to Rett syndrome phenotypes\", \"Whether the loop is cell-type specific within brain\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping of three homeodomain-response elements in the Runx2-P1 promoter directly bound and transactivated by DLX5 (and antagonized by MSX2) confirmed DLX5 as a direct upstream activator of Runx2 transcription.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis of individual elements, promoter-reporter assay in C2C12 cells\",\n      \"pmids\": [\"16115867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo ChIP validation at endogenous Runx2 locus not yet performed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that p38 MAPK phosphorylates DLX5 at Ser-34 and Ser-217 to enhance its transactivation of the Osterix promoter revealed a key post-translational mechanism integrating MAPK signaling with the osteogenic transcription factor cascade.\",\n      \"evidence\": \"In vitro kinase assay, phosphosite mutagenesis, ChIP at Osterix promoter, BMP-2-stimulated osteoblasts\",\n      \"pmids\": [\"18056716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other kinases target these same sites in vivo\", \"Crystal structure of phospho-DLX5 not available\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Dlx5-null osteoblast analysis showed that DLX5 regulates the RANKL/OPG ratio, linking it to osteoblast-osteoclast coupling, while TGF-β receptor conditional knockouts demonstrated that TGF-β suppresses Dlx5 to maintain chondrogenic potential over osteogenic fate.\",\n      \"evidence\": \"Dlx5 null mouse femur analysis; co-culture osteoclastogenesis assay; compound Tgfbr2/Dlx5 conditional knockout rescue\",\n      \"pmids\": [\"18669617\", \"18684439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX5 directly controls RANKL or OPG promoters\", \"Full epistatic relationship between TGF-β and BMP at the Dlx5 promoter\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of MYC and IRS-2 as direct DLX5 transcriptional targets (confirmed by EMSA and ChIP) established pro-proliferative functions for DLX5 in cancer via MYC activation and IRS-2/AKT signaling, extending its role beyond developmental contexts.\",\n      \"evidence\": \"EMSA, ChIP, luciferase reporters, siRNA/shRNA knockdown with rescue by MYC or constitutively active AKT; xenograft tumor assays\",\n      \"pmids\": [\"19497851\", \"21045156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DLX5 oncogenic functions depend on the same phosphorylation events as osteogenic functions\", \"Prevalence of DLX5 activation across cancer types\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"CaMKII phosphorylation of DLX5 increases its protein stability and osteoblastogenic transactivation, adding a second kinase pathway that post-translationally amplifies DLX5 activity.\",\n      \"evidence\": \"In vitro kinase assay; protein stability assay; transcriptional reporter; KN-93 pharmacological inhibition\",\n      \"pmids\": [\"19393622\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific CaMKII phosphorylation sites on DLX5 not mapped\", \"In vivo confirmation of CaMKII-DLX5 axis not provided\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Dlx5/Dlx6 were shown to be required for parvalbumin-positive cortical interneuron development and tangential migration; heterozygous loss caused spontaneous seizures and impaired gamma oscillations, linking Dlx5/6 dosage to circuit-level function.\",\n      \"evidence\": \"Conditional knockout; interneuron transplantation assay; EEG recording; immunohistochemistry; CXCR4 expression analysis\",\n      \"pmids\": [\"20392955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of DLX5 in interneurons not identified\", \"Whether seizure phenotype is specifically due to parvalbumin+ neuron loss\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Hand2 was identified as a negative-feedback regulator of Dlx5/6 in distal mandibular arch mesenchyme; failure to repress Dlx5/6 causes ectopic bone and aglossia, resolving how Dlx5/6 expression is spatially refined.\",\n      \"evidence\": \"Conditional knockout of Hand2; compound Hand2/Dlx5/6 mutants; in situ hybridization\",\n      \"pmids\": [\"21558373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hand2 directly binds Dlx5/6 regulatory regions\", \"Mechanism of Dlx5/6 repression by Hand2 unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"In vivo ChIP and enhancer mutagenesis in transgenic mice demonstrated that DLX5 and MEF2 directly bind a conserved enhancer 30 kb upstream of Runx2, required for osteoblast-specific Runx2 expression, defining the cis-regulatory architecture of this key osteogenic locus.\",\n      \"evidence\": \"BAC reporter mouse; serial deletion and in vivo mutagenesis of binding sites; ChIP in primary osteoblasts; histone modification analysis\",\n      \"pmids\": [\"24692107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Three-dimensional chromatin topology at the Runx2 locus not characterized\", \"Whether this enhancer operates in chondrocytes\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"GABAergic-specific Dlx5/6 inactivation reduced anxiety, obsessive-compulsive behaviors, adiposity, and extended lifespan by 33%, revealing unexpected metabolic and longevity roles for Dlx5/6 in mature GABAergic circuits.\",\n      \"evidence\": \"Conditional knockout (Vgat-Cre; Dlx5/6 flox); behavioral testing; body composition and survival analysis\",\n      \"pmids\": [\"31514171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream metabolic effectors in GABAergic neurons not identified\", \"Whether longevity effect is due to reduced adiposity or altered behavior\", \"Independent replication needed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genome-wide chromatin profiling revealed that DLX5 cooperates with TP63 at ~2000 enhancers in squamous cell carcinoma, with DLX5 reactivation driven by SOX2-mediated switching of its promoter from bivalent to active chromatin state.\",\n      \"evidence\": \"ATAC-seq, ChIP-seq, ELMER analysis, shRNA knockdown, xenograft assay in ESCC\",\n      \"pmids\": [\"34370013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction between DLX5 and TP63 not confirmed\", \"Mechanism by which DLX5 selects enhancers genome-wide unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the complete set of direct DLX5 transcriptional targets in GABAergic interneurons, the structural basis for homeodomain-mediated partner interactions, and whether post-translational modifications that enhance osteogenic DLX5 activity also operate in neural or oncogenic contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No genome-wide direct target map (CUT&RUN/ChIP-seq) in interneurons\", \"No crystal or cryo-EM structure of DLX5 homeodomain in complex with DNA or protein partners\", \"Phosphorylation-site mapping in neural tissues not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 6, 7, 10, 17, 22, 32, 38]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 6, 7, 10, 16, 17, 30, 32, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 6, 7, 10, 15, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 12, 13, 14, 18, 25, 36, 40]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 3, 6, 7, 10, 17, 22, 30, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 3, 10, 21, 27]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MSX2\",\n      \"RUNX2\",\n      \"DLXIN1\",\n      \"PRAJA1\",\n      \"DLX6\",\n      \"TP63\",\n      \"MEF2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}